As pharmaceutical and medical device manufacturers grapple with changing labeling requirements, streamlining their processes could provide support.
By Josh Roffman, Vice President, Marketing and Product Management
Evolving supply chain themes and technological advancements in the pharmaceutical and medical device industries are compelling businesses to look at labeling differently. A variety of developing trends in enterprise labeling are driving these leading global businesses to reassess their supply-chain strategy to streamline their processes, meet compliance, and initiate best practices.
Strict regulations and standards guide the preparation of medication at hospitals, but unfortunately, these are not always followed. In the operating room, where procedures and decisions often happen rapidly, noncompliance is especially common and can have dangerous consequences.
By Neil Gleghorn, Managing Director
Patient safety is of utmost concern in the medical device sector, which means that products need to adhere to all sorts of strict controls--to ensure not only their quality, but also their absolutely traceability right back to their original source. Those requirements are being stepped up to new levels as part of a general wave of improvements to the way health-related products are managed and monitored.
Dave Robinson was just two years old when his father Mike became owner of Robinson Printing, so he has long witnessed—and now helps guide—the family-owned company’s ongoing growth. Celebrating its 90th year in business in 2014, Robinson Printing continues to evolve in terms of technology and capability, offering labeling innovations to solve real-life customer challenges.
Mike Miller has seen a steady increase in the required information and font sizes needed for pharmaceutical labeling. “This continued increase requires our clients to expand their packaging and find creative ways to deliver that information,” says Miller, who is vice president of manufacturing and co-founder of Platinum Press Inc. (Grand Prairie, TX; www.platinumpress.com.).
The Carlyle Group has acquired global paper-based packaging supplier Chesapeake from Irving Place Capital and funds managed by Oaktree Capital Management, it was reported in a statement. Chesapeake manufactures leaflets, labels, and cartons, primarily for the pharmaceutical, confectionery, and premium drinks industries. With headquarters in Nottingham, UK, the company employs nearly 5000 at 38 facilities in nine countries and had revenues of €580m in 2012.
ISPE, the International Society for Pharmaceutical Engineering, reports that it is surveying patients globally on their experiences with clinical trial materials. The goal is to gather feedback on the suitability of clinical trial packaging, label information and design, interacting with clinical trial technologies, and transportation and storage, ISPE reports in a press release. With a target of 2000 or more patients from around the world, this study is the first known of its kind in size and scope, it reports.
West Pharmaceutical Services Inc.’s Carol Mooney, Global Market Segment Director, Pharma/Biotech, offers guidance on complying with the new standards.
Q. How does the new standard impact pharmaceutical packaging?